UMIN-CTR Clinical Trial

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Recruitment status Completed
Unique ID issued by UMIN UMIN000036774
Receipt No. R000041906
Scientific Title Study to verify how the use of the test mattress has an effect on skin quality, sleep quality and fatigue
Date of disclosure of the study information 2019/05/17
Last modified on 2019/10/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments

Basic information
Public title Study to verify how the use of the test mattress has an effect on skin quality, sleep quality and fatigue
Acronym Study to verify how the use of the test mattress has an effect on skin quality, sleep quality and fatigue
Scientific Title Study to verify how the use of the test mattress has an effect on skin quality, sleep quality and fatigue
Scientific Title:Acronym Study to verify how the use of the test mattress has an effect on skin quality, sleep quality and fatigue

Condition Healthy volunteer
Classification by specialty
Classification by malignancy Others
Genomic information NO

Narrative objectives1 The purpose of this study is to verify the effect of using test bedding (4-layer special three-dimensional mattress "AiR SX") on skin quality, sleep quality and fatigue.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Primary outcomes The stratum corneum water content,The transepidermal water loss,The skin elasticity,VISIA,(Week 0, Week 4, Week 8)
Key secondary outcomes OSA sleep inventory MA version,Japanese version of the Pittsburgh Sleep Quality Index,Questionnaire on fatigue(VAS),Salivary cortisol,(Week 0, Week 4, Week 8)

Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Dynamic allocation
Institution consideration

No. of arms 1
Purpose of intervention Treatment
Type of intervention
Interventions/Control_1 Use 4-layer special three-dimensional mattress

Age-lower limit
40 years-old <=
Age-upper limit
60 years-old >
Gender Female
Key inclusion criteria [1]Japanese females aged 40-59 years
[2]Individuals who are healthy and are not received treatment of disease
[3]Individuals who are concerned about skin dryness and stiffness
[4]Individuals who are not satisfy quality of sleep
[5]Individuals whose sleeping hours are over 4 hours from lights-out to rising and time of lights-out and rising is regular and bedtime is every 24th hours
[6]Individuals whose written informed consent has been obtained
[7]Individuals who can come to the designated examination date and receive the examination
[8]Individuals judged appropriate for the study by the principal
Key exclusion criteria [1]Individuals using medical products
[2]Individuals with skin disease, such as atopic dermatitis
[3]Individuals who have an inflammation or a scar on a measuring area
[4]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders
[5]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.)
[6]Individuals who are suspected, recived treatment of, or have a history of sleep apnea syndrome
[7]Individuals who have or are suspected with the night urination, prostatomegaly, or overactive bladder
[8]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc.
[9]Individuals with >=25.0kg/m2 BMI
[10]Individuals who have the possibility of developing seasonal allergic symptoms such as hay fever and the possibility of using medicines (eyedrops, nose drops are acceptable)
[11]Individuals who have a regular intake of supplements and health food products that have an effect on skin quality improvement and fatigue, and individuals who are scheduled to take it during the test period (but not applicable to those who can stop taking it at the time of obtaining consent)
[12]Individuals who have a habit of taking alcohol
[13]Individuals with alcoholism or other mental disorders
[14]Individuals whose life style will change during the test period (ex. travel for a long time)

Target sample size 12

Research contact person
Name of lead principal investigator
1st name Yoshikazu
Middle name
Last name Yonei
Organization Faculty of Life and Medical Sciences,Doshisha University
Division name Anti-Aging Medical Research Center
Zip code 6100394
Address 1-3 Tatara Miyakodani,Kyotanabe City,Kyoto
TEL 0774-65-6394

Public contact
Name of contact person
1st name Toshiyasu
Middle name
Last name Tamura
Organization TES Holdings Co., Ltd.
Division name Department of Clinical Trial
Zip code 1100015
Address 6F,Kairaku Bldg,2-7-5 Higashi-Ueno,Taitou-ku,Tokyo
TEL 03-6801-8400
Homepage URL

Institute Anti-Aging Bank Co.,Ltd.

Funding Source
Organization Nishikawa Co., Ltd.
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Name of secondary funder(s)

IRB Contact (For public release)
Organization Society of Glycative Stress Research
Address 5F-11,Musashino Bldg,2-13-10 Shinjuku,Shinjuku-ku,Tokyo
Tel 03-6709-8842

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2

Institutions うえのあさがおクリニック

Other administrative information
Date of disclosure of the study information
2019 Year 05 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

URL related to results and publications
Number of participants that the trial has enrolled 12
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Recruitment status Completed
Date of protocol fixation
2019 Year 04 Month 23 Day
Date of IRB
2019 Year 04 Month 26 Day
Anticipated trial start date
2019 Year 05 Month 18 Day
Last follow-up date
2019 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other related information

Management information
Registered date
2019 Year 05 Month 16 Day
Last modified on
2019 Year 10 Month 03 Day

Link to view the page

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name

Contact us.